Physician
Infectious Disease
Dr. Lynne M. Mofenson, MD
Lynne M. Mofenson works in the field of Infectious Disease. He attended Albert Einstein College of Medicine of Yeshiva University. He has 1 awards "Fellow (FAAP)". Lynne Mofenson is a published MD. He published 52 publications, including: 'Maternal Highly Active Antiretroviral Therapy and Child HIV-Free Survival in Malawi, 2004-2009.'
Publications
- Maternal Highly Active Antiretroviral Therapy and Child HIV-Free Survival in Malawi, 2004-2009.
- Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers.
- A Multi-Disciplinary Approach to Implementation Science: The NIH-PEPFAR PMTCT Implementation Science Alliance.
- Long-Term Safety and Efficacy of Atazanavir-Based Therapy in HIV-Infected Infants, Children and Adolescents: The Pediatric AIDS Clinical Trials Group Protocol 1020A.
- Predictors of Virologic and Clinical Response to Nevirapine versus Lopinavir/Ritonavir-based Antiretroviral Therapy in Young Children With and Without Prior Nevirapine...
- Raltegravir Pharmacokinetics in Neonates Following Maternal Dosing.
- Safety of pediatric HIV elimination: the growing population of HIV- and antiretroviral-exposed but uninfected infants.
- HIV Monoclonal Antibodies: A New Opportunity to Further Reduce Mother-to-Child HIV Transmission.
- Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis.
- Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046): 18-mont...
- Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children: Recommendations from the National Institutes of Healt...
- Prevention of mother-to-child HIV transmission: can we meet the goal of global elimination of new pediatric infections?
- Antibody Maturation and Viral Diversification in HIV-Infected Women.
- Combination antiretroviral use and preterm birth.
- Pooled individual data analysis of 5 randomized trials of infant nevirapine prophylaxis to prevent breast-milk HIV-1 transmission.
- Antiretrovirals in pregnancy: a note of caution.
- Evaluation of viral load thresholds for predicting new World Health Organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral t...
- Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants.
- Unresolved Antiretroviral Treatment Management Issues in HIV-Infected Children.
- Editorial: Prevention of Mother-to-Child HIV-1 Transmission - Why We Still Need a Preventive HIV Immunization Strategy.
- Effects of Cessation of Breastfeeding in HIV-1-Exposed, Uninfected Children in Malawi.
- Atazanavir and Atazanavir/Ritonavir Pharmacokinetics in HIV-Infected Infants, Children, and Adolescents.
- Analysis of nevirapine resistance in HIV-infected infants who received extended nevirapine or nevirapine/zidovudine prophylaxis.
- Initiation of Antiretroviral Treatment in Women After Delivery Can Induce Multiclass Drug Resistance in Breastfeeding HIV-Infected Infants.
- Post-Exposure Prophylaxis of Breastfeeding HIV-Exposed Infants with Antiretroviral Drugs to Age 14 Weeks: Updated Efficacy Results of the PEPI-Malawi Trial.
- Antiretroviral treatment for children with peripartum nevirapine exposure.
- Protecting the next generation--eliminating perinatal HIV-1 infection.
- Prevention in neglected subpopulations: prevention of mother-to-child transmission of HIV infection.
- Growing up with HIV: children, adolescents, and young adults with perinatally acquired HIV infection.
- Potential confounding of the association between exposure to nucleoside analogues and mitochondrial dysfunction in HIV-uninfected and indeterminate infants.
- Frequency of gastroenteritis and gastroenteritis-associated mortality with early weaning in HIV-1-uninfected children born to HIV-infected women in Malawi.
- Prevention of breast milk transmission of HIV: the time is now.
- Total lymphocyte count: not a surrogate marker for risk of death in HIV-infected Ugandan children.
- Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.
- Antiretroviral Prophylaxis to Reduce Breast Milk Transmission of HIV Type 1: New Data but Still Questions.
- International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settin...
- Recommendations for human immunodeficiency virus screening, prophylaxis, and treatment for pregnant women in the United States.
- Human immunodeficiency virus, mycobacterium tuberculosis, and pregnancy: a deadly combination.
- Pharmacokinetics and safety of indinavir in human immunodeficiency virus-infected pregnant women.
- Cotrimoxazole prophylaxis in HIV-infected pregnant women: only a first step.
- A behavioral and cognitive profile of clinically stable HIV-infected children.
- Association of selected phenotypic markers of lymphocyte activation and differentiation with perinatal human immunodeficiency virus transmission and infant infection.
- Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Soc...
- Efavirenz reclassified as FDA pregnancy category D.
- Successes and challenges in the perinatal HIV-1 epidemic in the United States as illustrated by the HIV-1 Serosurvey of childbearing women.
- Performance characteristics of HIV-1 culture and HIV-1 DNA and RNA amplification assays for early diagnosis of perinatal HIV-1 infection.
- Advances in the prevention of vertical transmission of human immunodeficiency virus.
- Tale of two epidemics--the continuing challenge of preventing mother-to-child transmission of human immunodeficiency virus.
- Antiretroviral therapy during pregnancy and the risk of an adverse outcome.
- Antiretroviral prophylaxis of perinatal HIV-1 transmission and the potential impact of antiretroviral resistance.
- Safety of antiretroviral prophylaxis of perinatal transmission for HIV-infected pregnant women and their infants.
Schools
Albert Einstein College of Medicine of Yeshiva University
Doctors Specialties
- Pediatrics
- Infectious Disease
Accepted Insurances
Awards
- Fellow (FAAP)
Education
-
Albert Einstein College of Medicine of Yeshiva University
Helpful Reviews
Similar Doctors
|
Dr. Elias K. Mamo, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kristen M. Bauer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lynette H. Posorske, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carla L. Epps, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan L. Lukacs, DO |
|
|
Dr. Graciano P. Gancayco, MD |
|
|
Dr. Thomas G. Tanton, MD |
|
|
Dr. Patience A. Williams, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Padmaja S. Udapi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah M. Connelly, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth M. O'Shaughnessy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter S. Miele, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Najla N. Falaki, MB BCH
This Doctor is OpenDoctor Recommended.
|